A Phase IB 2 Dose Trial of IRS-1 HSV C134 (IND 17296) Administered Intratumorally in Patients With Recurrent Malignant Glioma

NCT06614855 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

12

Enrollment

OTHER

Sponsor class

Conditions

Glioblastoma
Glioblastoma (GBM)
Astrocytoma
Astrocytoma, Grade III
Astrocytoma, Grade IV
Gliosarcoma, Adult
Gliosarcoma of Brain

Interventions

DRUG: C134
DRUG: C134

Sponsor

James Markert, MD